Yaakov Elkon, CEO of Graphnet, Inc., Awarded the 2009 Tower of Hope Corporate Excellence from The Israel Cancer Research Fund

NEW YORK, Nov. 5 /PRNewswire/ -- Graphnet, Inc., a leading provider of enterprise-grade, business messaging, today announced that their CEO, Yaakov Elkon won the 2009 Tower of Hope Corporate Excellence award from The Israel Cancer Research Fund (ICRF) during their annual gala that took place last night in New York.

The Israel Cancer Research Fund (ICRF) is a voluntary charitable organization that receives its total income from private donations. ICRF was founded in 1975 by a group of American and Canadian researchers, oncologists, and lay people determined to harness Israel's educational and scientific resources in the fight against cancer. Its initial purpose was to fund Israeli researchers for postdoctoral fellowships of young Ph.D.'s. ICRF is the only U.S.-based charity solely devoted to supporting cancer research in Israel, which has a direct impact to the global fight of cancer.

The goal of the event is to celebrate the achievements and the vision of ICRF's research scientists, physicians, philanthropists and heroes who are dedicated and devoted professionals that make our world a better place each and every day. The secondary goal is to continue to raise awareness and funding for cancer research. The gala took place November 4, 2009 and was attended by Ambassador, Asaf Shariv, The Consul General of Israel, and special guest, Dr. Yoav Henis, Tel Aviv University.

Additional distinguished 2009 award recipients include:

• Richard Axel, MD, Tower of Hope Excellence in Science Award
• Barbara Edelstein, MD, Tower of Hope Excellence in Medicine Award
• Daniel G. Miller, MD, Tower of Hope Excellence in Medicine Award
• Mark Sultan, MD, FACS, Tower of Hope Excellence in Surgery Award
  

"This is a huge honor for me to receive this award and to be in such amazing company as my co-winners," said Yaakov Elkon, CEO of Graphnet, Inc., and corporate member of ICRF. Mr. Elkon continues, "As a strong believer in the overall mission of ICRF: to support cancer research in Israel, for the benefit of Israel and all mankind; all stakeholders within ICRF is contributing and making important discoveries with the global fight against cancer. I continue to support ICRF because I expect great things to happen in the next several years as the efforts of the foundation come to fruition - specific cures for specific cancers."

For more information visit: http://www.icrfonline.org/index.htm

About The Israel Cancer Research Fund/ICRF

Since its inception, ICRF has provided more than $33 million to support innovative studies by Israeli scientists. Our awardees are selected through a rigorous peer-review process that is conducted by a world-class scientific panel. We support individuals at all of the major research institutions in Israel. ICRF-funded researchers have been making significant progress and have been able to develop improved chemotherapies, advanced techniques in bone marrow transplantation, and an enhanced understanding of tumor suppressor genes.

About Graphnet

Graphnet, founded in 1968, is an innovative, leading provider of enterprise level business messaging solutions. We provide comprehensive integration and development services to ensure client-specific solutions that are always bundled with transport, while our detailed policies and procedures safeguard customer privacy and information confidentiality. With a proprietary Research and Development department, our technologies enable constant network availability with interruption-free business continuity. Our offices span the globe, providing quality communications services to government agencies, associations, and Fortune 1000 enterprises that operate businesses worldwide.

SOURCE Graphnet, Inc.